CD8A and COVID-19: Taken together, these results indicate that immunization with the pan-variant SARS-CoV-2 vaccine bearing conserved epitopes induced cross-protective CD8+ and CD4+ T cells that infiltrated the lungs, faciltated clearance of virus, and reduced COVID-19-related lung pathology following infection with various multiple SARS-CoV-2 variants.